David Santos
Corporate Officer/Principal bei RIGEL PHARMACEUTICALS, INC.
Vermögen: 341 413 $ am 31.05.2024
Profil
David A.
Santos is currently the Chief Commercial Officer & Executive VP at Rigel Pharmaceuticals, Inc. He previously worked as the Vice President-Kinase Inhibitor at Amgen, Inc. and as the Head-Hematology at Jazz Pharmaceuticals, Inc. From 2014 to 2015, he held the position of Vice President-Sales & Marketing at Pfizer Inc. Mr. Santos completed his undergraduate degree at St. Louis University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.02.2024 | 349 093 ( 0,20% ) | 341 413 $ | 31.05.2024 |
Aktive Positionen von David Santos
| Unternehmen | Position | Beginn |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2020 |
Ehemalige bekannte Positionen von David Santos
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Vertrieb & Marketing | 01.05.2015 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Ausbildung von David Santos
| St. Louis University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
